一个突变过程的签名和基因组变化与结果和免疫性相关的癌症与大脑转移的癌症
Wanli Sun1, Xueying Wang2, Yixin Xu3
1Department of Clinical Laboratory, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong, China.
Frontiers in immunology
|August 14, 2025
概括
这项研究确定了脑转移 (BM) 患者的关键体质突变和基因组变异. 发现像PTPRT突变这样的生物标志物可以改善预后,并预测免疫治疗反应.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 癌症研究 癌症研究
背景情况:
- 大脑转移 (BM) 是癌症护理的一个重大挑战,通常与患者预后不佳有关.
- 了解BM的基因组景观对于开发向疗法和改善患者治疗结果至关重要.
研究的目的:
- 通过使用体质突变数据,识别潜在的生物标志物,用于预后评估和脑转移患者的免疫性预测.
- 探索突变特征,分子亚型和大脑转移中的临床结果之间的关系.
主要方法:
- 对421名脑转移患者的体质突变概况和临床数据的分析.
- 利用非负矩阵因数分解来提取突变过程的特征,以及用于分子亚型识别的共识聚类.
- 对基因组突变和拷贝数变异 (CNV) 的全面分析,以选与结果和免疫性相关的生物标志物.
主要成果:
- 非小细胞肺癌,黑色素瘤和乳腺癌是常见的原发性瘤,具有更好的BM预后.
- 较高的瘤突变负担 (TMB) 与更好的预后相关;特定的C>T突变特征表明结果较差.
- PTPRT突变与改善的预后和更好的免疫治疗反应有关,而PTEN删除表明结果较差,DUSP4删除表明结果更好.
结论:
- 综合体质突变数据确定了BM预后和免疫性分子生物标志物.
- 研究结果为预后评估提供了洞察力,并为预测脑转移患者免疫疗法的疗效奠定了基础.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


